This prospective, multicenter, randomized, double-blind, parallel group, comparative study evaluated and compared contrast-induced patient discomfort, overall safety and image quality following ...

The ISOVUE IBP allows for easy and cost-effective intravenous contrast enhancement of CT imaging of the head and body in adult and pediatric patients. The ISOVUE IBP provides 10-hour on-demand dosing ...

Iopamidol 755mg/mL; soln for intravascular administration; contains sodium 0.053mg, organically bound iodine 370mg per mL. For angiography throughout the cardiovascular system, including cerebral and ...

Please provide your email address to receive an email when new articles are posted on . Eleven patients reported 22 reactions during intradermal testing. Nine of 11 patients displayed cross-reactivity ...

Princeton, NJ - The manufacturers of iopamidol (Isovue, Bracco Diagnostics) power-injector syringes have initiated a voluntary class 1 recall because of evidence of particulate matter in retained ...

Iopamidol 510mg/mL; soln for intra-arterial or IV use; contains sodium 0.036mg, organically bound iodine 250mg per mL. lopamidol enhances computed tomographic brain imaging through augmentation of ...

DENVER — Compared with iopamidol, iodixanol, a lower-iodine-content contrast agent, was found to benefit patient comfort, including rates of chest and arm pain, and decreased the likelihood of ...

CHICAGO -- Patients who underwent abdominal or pelvic CT imaging with a low-osmolar contrast agent reported more discomfort during the exam than patients who received an iso-osmolar agent, researchers ...

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...

Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...